PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2023

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 67 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
DENALI ADVISORS LLC 110,200$220,4000.08%
Orin Green Financial, LLC 60,150$120,3000.06%
XTX Topco Ltd 170,878$341,7560.06%
EAM Investors, LLC 165,631$331,2620.06%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$51,9480.03%
HARBOUR INVESTMENT MANAGEMENT LLC 10,100$20,2000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 158,790$317,5800.01%
Truvestments Capital LLC 3,880$7,7600.00%
IHT Wealth Management, LLC 28,800$57,6000.00%
Virtu Financial LLC 12,108$240.00%
NATIXIS 132,000$264,0000.00%
MARSHALL WACE, LLP 562,139$1,124,2780.00%
Renaissance Technologies 659,300$1,3190.00%
Aptus Capital Advisors, LLC 16,760$33,5200.00%
Connor, Clark & Lunn Investment Management Ltd. 115,539$231,0780.00%
Sculptor Capital LP 37,000$74,0000.00%
Sculptor Capital LP 37,000$74,0000.00%
NATIONAL BANK OF CANADA /FI/ 303,800$559,7850.00%
Verition Fund Management LLC 54,474$108,9480.00%
BANK OF AMERICA CORP /DE/ 70,764$141,5280.00%
External links

This page lists PROTALIX BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view PROTALIX BIOTHERAPEUTICS INC's shareholder history, click here.